Our global presence is strong, thanks to our skilled colleagues and partners in all the major pharmaceutical markets. This is the key to our accelerated growth and will lay the foundation for future regional and global innovation.
We are more than 600 employees in Denmark and at our affiliates in the US, China, UK, Ireland, Germany, Sweden and Norway. Pharmacosmos is currently represented in 40 countries through our own affiliates and dedicated partners around the globe.
Pharmacosmos Therapeutics Inc. fosters a collaborative, performance-driven culture that acknowledges and rewards employees for their contributions. Empowered to engage in meaningful work, our team embodies the company’s core values.
Established on 1 September 2020, during the Covid pandemic, Pharmacosmos China has triumphed over challenges and demonstrated resilience and commitment to our core values.
Pharmacosmos Germany, founded in Wiesbaden on 1 February 2017, specialises in marketing and distributing products for the treatment of iron deficiency and iron deficiency anaemia in Germany.
Our oldest pharma affiliate, established in 2011 and with its head office in Reading, Pharmacosmos UK/IE focuses on marketing products for and supporting the treatment of iron deficiency in the UK and Ireland.
Covering a vast geographical area, Pharmacosmos Nordic spans Denmark, Sweden, Norway, Finland and Iceland. Consolidating sales activities in June 2010, the local affiliates in the Nordic countries play a pivotal role in our regional presence.
Ein globaler Pionier in der Kohlenhydratchemie und ein führendes Unternehmen in der Entwicklung innovativer Behandlungen für Patienten, die an Eisenmangel und Eisenmangelanämie leiden.
